Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Declines By 66.7%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totalling 200 shares, a drop of 66.7% from the December 15th total of 600 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is presently 0.3 days.

Mosaic ImmunoEngineering Stock Performance

Shares of CPMV traded down $0.00 during mid-day trading on Wednesday, reaching $0.94. The company had a trading volume of 127 shares, compared to its average volume of 1,375. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13. The company has a market capitalization of $6.81 million, a price-to-earnings ratio of -6.27 and a beta of 0.27. The company’s 50 day simple moving average is $0.89 and its 200 day simple moving average is $0.86.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.